Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Otago Medical School staff profiles

Dr Peter Ganly

PositionClinical Senior Lecturer
DepartmentDepartment of Pathology and Biomedical Science(UOC)
QualificationsBM BCh(Oxon), MA, PhD(Canterbury), MRCP, FRCPath, FRCPEd, FRCPA
Research summaryCancer

Research

Dr Ganly's expertise and interests include the diagnosis and management of malignant haematological diseases, stem cell transplantation and clinical research.

Publications

Mascarenhas, J., Virtgaym, E., Stal, M., Blacklock, H., Gerds, A. T., Mesa, R., Ganly, P., … Moshier, E. (2018). Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: A sponsor-independent international study. Annals of Hematology. Advance online publication. doi: 10.1007/s00277-018-3309-6

Hock, B. D., Mulholland, K. S., Ganly, P., McKenzie, J. L., Pearson, J. F., & Macpherson, S. A. (2018). Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.14155

Gerstung, M., Papaemmanuil, E., Martincorena, I., Bullinger, L., Gaidzik, V. I., Paschka, P., … Ganly, P., … Campbell, P. J. (2017). Precision oncology for acute myeloid leukemia using a knowledge bank approach. Nature Genetics, 49, 332-340. doi: 10.1038/ng.3756

Bolli, N., Li, Y., Sathiaseelan, V., Raine, K., Jones, D., Ganly, P., … Munshi, N. C. (2016). A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma. Blood Cancer Journal, 6(9), e467. doi: 10.1038/bcj.2016.72

Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., … Ganly, P., … Campbell, P. J. (2016). Genomic classification and prognosis in acute myeloid leukemia. New England Journal of Medicine, 374(23), 2209-2221. doi: 10.1056/NEJMoa1516192

Journal - Research Article

Mascarenhas, J., Virtgaym, E., Stal, M., Blacklock, H., Gerds, A. T., Mesa, R., Ganly, P., … Moshier, E. (2018). Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: A sponsor-independent international study. Annals of Hematology. Advance online publication. doi: 10.1007/s00277-018-3309-6

Hock, B. D., Mulholland, K. S., Ganly, P., McKenzie, J. L., Pearson, J. F., & Macpherson, S. A. (2018). Impact of increased access to novel agents on the survival of multiple myeloma patients treated at a single New Zealand centre. Internal Medicine Journal. Advance online publication. doi: 10.1111/imj.14155

Gerstung, M., Papaemmanuil, E., Martincorena, I., Bullinger, L., Gaidzik, V. I., Paschka, P., … Ganly, P., … Campbell, P. J. (2017). Precision oncology for acute myeloid leukemia using a knowledge bank approach. Nature Genetics, 49, 332-340. doi: 10.1038/ng.3756

Bolli, N., Li, Y., Sathiaseelan, V., Raine, K., Jones, D., Ganly, P., … Munshi, N. C. (2016). A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma. Blood Cancer Journal, 6(9), e467. doi: 10.1038/bcj.2016.72

Papaemmanuil, E., Gerstung, M., Bullinger, L., Gaidzik, V. I., Paschka, P., Roberts, N. D., … Ganly, P., … Campbell, P. J. (2016). Genomic classification and prognosis in acute myeloid leukemia. New England Journal of Medicine, 374(23), 2209-2221. doi: 10.1056/NEJMoa1516192

Ganly, P., Cole, S., Trengrove, A., & Butler, A. (2014). Outcomes of allogeneic haematopoietic stem cell transplants at a small New Zealand centre: Does size matter? Internal Medicine Journal, 44(7), 683-689. doi: 10.1111/imj.12456

Fernyhough, L. J., Hock, B. D., Taylor, J., Pearson, J., & Ganly, P. (2013). Survival of myeloma patients following the introduction of thalidomide as a second-line therapy: A retrospective study at a single New Zealand centre. Internal Medicine Journal, 43(2), 130-137. doi: 10.1111/j.1445-5994.2012.02819.x

Robak, T., Dmoszynska, A., Solal-Céligny, P., Warzocha, K., Loscertales, J., . . ., Ganly, P. S., & et al (2010). Rituximab plus fludarabine and cyclophosphamide prolongs progression-free survival compared with fludarabine and cyclophosphamide alone in previously treated chronic lymphocytic leukemia. Journal of Clinical Oncology, 28(10), 1756-1765. doi: 10.1200/JCO.2009.26.4556

Marr, H., McDonald, E.-J., Merriman, E., Smith, M., Mangos, H., Stoddart, C., & Ganly, P. (2009). Successful treatment of transplant-associated microangiopathy with rituximab [Clinical correspondence]. New Zealand Medical Journal, 122(1292). Retrieved from http://journal.nzma.org.nz/journal/122-1292/3534/content.pdf

Hernandez, E., Ganly, P., Charu, V., DiBenedetto, J., Tomita, D., Lillie, T., … ARANESP 20030232 Study Group. (2009). Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. Current Medical Research & Opinion, 25(9), 2109-2120. doi: 10.1185/03007990903084164

Ganly, P. S., Keeman, H., Spearing, R. L., Smith, M. P., Patton, N., Merriman, E. G., & Gibbons, S. S. (2008). Written advice can provide a safe and acceptable alternative to new patient assessment for selected referrals to haematologists. Medical Journal of Australia, 188(1), 9-12.

Sanders, J., Pithie, A., Ganly, P., Surgenor, L., Wilson, R., Merriman, E., … Chambers, S. (2008). A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. Journal of Antimicrobial Chemotherapy, 62(4), 809-815. doi: 10.1093/jac/dkn284

Ganly, P., Hanrahan, V., Baker, B., & Romeril, K. (2007). Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera. American Journal of Hematology, 82, 80-82.

Ganly, P., & Spearing, R. (2006). Treatment with intravenous immunoglobulin is not a panacea but should be limited to those who can benefit [Editorial]. New Zealand Medical Journal, 119(1246). Retrieved from http://journal.nzma.org.nz/journal/119-1246/2335/content.pdf

Gough, S. M., Benjes, S. M., McDonald, M., Heaton, D., Ganly, P., & Morris, C. M. (2006). Translocation (5;10)(q22;q24) in a case of acute lymphoblastic leukemia. Cancer Genetics & Cytogenetics, 165, 36-40.

Chambers, S. T., Sanders, J., Patton, W. N., Ganly, P., Birch, M., Crump, J. A., & Spearing, R. L. (2005). Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: Results from a prospective randomized controlled trial. Journal of Hospital Infection, 61, 53-61.

Ganly, P., McDonald, M., Spearing, R., & Morris, C. M. (2004). Constitutional t(5;7)(q11;p15) rearranged to acquire monosomy 7q and trisomy 1q in a patient with myelodysplastic syndrome transforming to acute myelocytic leukemia. Cancer Genetics & Cytogenetics, 149(2), 125-130.

Ganly, P. S., Walker, L. C., & Morris, C. M. (2004). Familial mutations of the transcription factor RUNX1 (AML1, CBFA2) predispose to acute myeloid leukemia. Leukemia & Lymphoma, 45(1), 1-10.

Carradice, D., Austin, N., Bayston, K., & Ganly, P. S. (2002). Successful treatment of acute promyelocytic leukaemia during pregnancy. Clinical & Laboratory Haematology, 24, 307-311.

Mullin, J. L., Brennan, S., Ganly, P. S., & George, P. M. (2002). Fibrinogen Hillsborough: A Novel γ309Gly→ Asp Dysfibrinogen. Blood, 99, 3597-3610.

Walker, L. C., Campbell, H. J., Corbett, R., Spearing, R. L., Heaton, D. C., Macdonald, D. H., Morris, C. M., & Ganly, P. S. (2002). A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemia. British Journal of Haematology, 117(4), 878-881. doi: 10.1046/j.1365-2141.2002.03512.x

Whittle, A. T., Davis, M., Shovlin, C. L., Ganly, P. S., Haslett, C., & Greening, A. P. (2001). Alveolar macrophage activity and the pulmonary complications of haematopoietic stem cell transplantation. Thorax, 56, 941-946.

Ganly, P. S., & Beard, M. (2001). Osteoclasts in Paget's disease of bone. British Journal of Haematology, 113, 259.

Jackson, G., Taylor, P., Smith, G. M., Marcus, R., Smith, A., Chu, P., … Ganly, P. S., … Wilson, M. P. (2001). A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine abd granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. British Journal of Haematology, 112(1), , 127-137. doi: 10.1046/j.1365-2141.2001.02551.x

^ Top of page

Journal - Research Other

Ganly, P., Downing, J., Stiven, P., Frizelle, F., & Badami, K. (2011). Clinical and serological diagnoses of a patient with vancomycin-induced thrombocytopenia [Letter to the editor]. Transfusion Medicine, 21(2), 137-139. doi: 10.1111/j.1365-3148.2010.01052.x

Ganly, P., Saleem, M., Marr, H., Burt, M., Florkowski, C., & Williamson, A. (2008). Not walking or communicating: Is all well? [Case report]. Lancet, 372(9655), 2086. doi: 10.1016/S0140-6736(08)61870-X

More publications...